Andreas Wicki - Net Worth and Insider Trading

Andreas Wicki Net Worth

The estimated net worth of Andreas Wicki is at least $172 Million dollars as of 2024-11-05. Andreas Wicki is the Director of Viela Bio Inc and owns about 1,750,000 shares of Viela Bio Inc (VIE) stock worth over $93 Million. Andreas Wicki is the Director of Harmony Biosciences Holdings Inc and owns about 2,147,943 shares of Harmony Biosciences Holdings Inc (HRMY) stock worth over $72 Million. Andreas Wicki is also the Director of Pacira BioSciences Inc and owns about 451,324 shares of Pacira BioSciences Inc (PCRX) stock worth over $8 Million. Details can be seen in Andreas Wicki's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andreas Wicki has not made any transactions after 2022-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andreas Wicki

To

Andreas Wicki Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andreas Wicki owns 3 companies in total, including Pacira BioSciences Inc (PCRX) , Harmony Biosciences Holdings Inc (HRMY) , and Viela Bio Inc (VIE) .

Click here to see the complete history of Andreas Wicki’s form 4 insider trades.

Insider Ownership Summary of Andreas Wicki

Ticker Comapny Transaction Date Type of Owner
PCRX Pacira BioSciences Inc 2021-03-15 director
HRMY Harmony Biosciences Holdings Inc 2022-12-14 director
VIE Viela Bio Inc 2019-10-07 director

Andreas Wicki Latest Holdings Summary

Andreas Wicki currently owns a total of 3 stocks. Among these stocks, Andreas Wicki owns 1,750,000 shares of Viela Bio Inc (VIE) as of October 7, 2019, with a value of $93 Million and a weighting of 53.83%. Andreas Wicki owns 2,147,943 shares of Harmony Biosciences Holdings Inc (HRMY) as of December 14, 2022, with a value of $72 Million and a weighting of 41.64%. Andreas Wicki also owns 451,324 shares of Pacira BioSciences Inc (PCRX) as of March 15, 2021, with a value of $8 Million and a weighting of 4.53%.

Latest Holdings of Andreas Wicki

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VIE Viela Bio Inc 2019-10-07 1,750,000 53.01 92,767,500
HRMY Harmony Biosciences Holdings Inc 2022-12-14 2,147,943 33.41 71,762,776
PCRX Pacira BioSciences Inc 2021-03-15 451,324 17.28 7,798,879

Holding Weightings of Andreas Wicki


Andreas Wicki Form 4 Trading Tracker

According to the SEC Form 4 filings, Andreas Wicki has made a total of 0 transactions in Viela Bio Inc (VIE) over the past 5 years. The most-recent trade in Viela Bio Inc is the acquisition of 500,000 shares on October 7, 2019, which cost Andreas Wicki around $10 Million.

According to the SEC Form 4 filings, Andreas Wicki has made a total of 11 transactions in Harmony Biosciences Holdings Inc (HRMY) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Harmony Biosciences Holdings Inc is the sale of 28,841 shares on December 14, 2022, which brought Andreas Wicki around $2 Million.

According to the SEC Form 4 filings, Andreas Wicki has made a total of 4 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 69,355 shares on March 15, 2021, which brought Andreas Wicki around $5 Million.

Insider Trading History of Andreas Wicki

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andreas Wicki Trading Performance

GuruFocus tracks the stock performance after each of Andreas Wicki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andreas Wicki is 42.55%. GuruFocus also compares Andreas Wicki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andreas Wicki within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andreas Wicki's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andreas Wicki

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.72 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Andreas Wicki Ownership Network

Ownership Network List of Andreas Wicki

No Data

Ownership Network Relation of Andreas Wicki

Insider Network Chart

Andreas Wicki Owned Company Details

What does Pacira BioSciences Inc do?

Who are the key executives at Pacira BioSciences Inc?

Andreas Wicki is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .

Pacira BioSciences Inc (PCRX) Insider Trades Summary

Over the past 18 months, Andreas Wicki made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 12,186 shares made by Lauren Bullaro Riker , a net sale of 9,754 shares made by Jonathan Slonin , and a net sale of 7,052 shares made by Daryl Gaugler .

In summary, during the past 3 months, insiders sold 500 shares of Pacira BioSciences Inc (PCRX) in total and bought 20,976 shares, with a net purchase of 20,476 shares. During the past 18 months, 224,391 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 203,415 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pacira BioSciences Inc Insider Transactions

No Available Data

Andreas Wicki Mailing Address

Above is the net worth, insider trading, and ownership report for Andreas Wicki. You might contact Andreas Wicki via mailing address: C/o Hbm Bioventures (cayman) Ltd., Centennial Towers,ste.305,2454 W.bay Rd., Grand Cayman E9 E9.